The diagnostic accuracy of the hand-held Raman spectrometer for the identification of anti-malarial drugs
Authors:
- Benjamin J. VisserBVBenjamin J. Visser
- Sophia G. de VriesSVSophia G. de Vries
- Emmanuel B. BacheEBEmmanuel B. Bache
- Janneke Meerveld-GerritsJMJanneke Meerveld-Gerrits
- Daniëlle KroonDKDaniëlle Kroon
- Jimmy BoersmaJBJimmy Boersma
- Selidji T. AgnandjiSASelidji T. Agnandji
- Michèle van VugtMVMichèle van Vugt
- Martin P. GrobuschMGMartin P. Grobusch
Open Access
- 15 March 2016
- journal article
- research article
- Published by Springer Nature in Malaria Journal
- Vol. 15 (1) , 160
Abstract
There is a need for accurate and field-applicable instruments for the evaluation of the quality of anti-malarial drugs. The aim of this study was to determine the diagnostic accuracy of the NanoRam®, a handheld Raman spectrometer (RS), to identify anti-malarial drugs. In total, 289 anti-malarial drugs collected in a randomized field survey in Gabon were evaluated. The samples were compared with authentic products as supplied by the official manufacturer. To determine the sensitivity and specificity of the handheld NanoRam® spectrometer in the identification of anti-malarial drugs, a two-gate reversed-flow design was applied. The standards for reporting of diagnostic accuracy studies (STARD) were followed. The index test was the handheld RS. The reference test standards were thin layer chromatography and high performance liquid chromatography with ultraviolet photo diode array detection. The sensitivity [95 % confidence interval (95 % CI)] and specificity of the RS to correctly identify an anti-malarial drug were 100 % (95 % CI 94.9–100 %) and 96 % (95 % CI 92.3–99.0 %), respectively. The RS could not differentiate between different batches of the same product or different manufacturers of the same product. Intra-observer agreement for 289 samples was 100 %. The average time to conduct the RS was 15 s per sample compared to 45 min per sample for TLC. The handheld RS holds promise as an easy-to-use, quick and field-applicable instrument for the evaluation of quality of anti-malarial drugs, potentially empowering pharmacists, drug inspectors and medical regulatory authorities. Trial registration NTR4341 (Dutch Trial Registry)Keywords
This publication has 38 references indexed in Scilit:
- Substandard and counterfeit medicines: a systematic review of the literatureBMJ Open, 2013
- The WWARN Antimalarial Quality SurveyorPathogens and Global Health, 2012
- Poor quality vital anti-malarials in Africa - an urgent neglected public health priorityMalaria Journal, 2011
- The Primacy of Public Health Considerations in Defining Poor Quality MedicinesPLOS Medicine, 2011
- Anti-malarial drug quality in Lagos and Accra - a comparison of various quality assessmentsMalaria Journal, 2010
- Hyperparasitaemia and low dosing are an important source of anti-malarial drug resistanceMalaria Journal, 2009
- Simple Field Assays to Check Quality of Current Artemisinin-Based Antimalarial Combination FormulationsPLOS ONE, 2009
- Pilot Study of Essential Drug Quality in Two Major Cities in IndiaPLOS ONE, 2009
- Guidelines for Field Surveys of the Quality of Medicines: A ProposalPLOS Medicine, 2009
- Fast detection and identification of counterfeit antimalarial tablets by Raman spectroscopyJournal of Raman Spectroscopy, 2006